NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
Back to search
Official data from USPTO
CAREMATT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
12/03/2024
Trademark type
Word
Nice classes
10
Filing date
02/04/2022
Registration date
12/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
08/01/2024
First use in commerce
08/01/2024
Drawing code
4
Owner type
16
Owner location
Denver, CO, US
Examiner
CROWDER-SCHAEFER, ANDREW W
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Medilogix, LLC
Representatives
MARK A. WATKINS VORYS, SATER, SEYMOUR AND PEASE LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Therapeutic mattresses for medical purposes; support mattressesfoam mattressesair mattressesadjustable bed framesaccessories therefor in the nature of pillowscushionsincontinence mattress padsall for medical use
Publications
History of USPTO decisions and trademark events.
44 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/03/2024
EXPT
EXPARTE APPEAL TERMINATED
11/05/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/20/2024
GNRT
NON-FINAL ACTION E-MAILED
08/20/2024
CNRT
NON-FINAL ACTION WRITTEN
08/20/2024
IUAA
USE AMENDMENT ACCEPTED
08/20/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/13/2024
IUAF
USE AMENDMENT FILED
08/13/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
08/13/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/13/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
08/12/2024
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
06/11/2024
GECD
ACTION DENYING REQ FOR RECON E-MAILED
06/11/2024
CNCF
ACTION CONTINUING FINAL - COMPLETED
06/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/25/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/23/2024
EXPI
EX PARTE APPEAL-INSTITUTED
05/23/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
05/23/2024
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
05/23/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/23/2024
GNFR
FINAL REFUSAL E-MAILED
02/23/2024
CNFR
FINAL REFUSAL WRITTEN
02/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2024
ALIE
ASSIGNED TO LIE
01/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/31/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/31/2023
GNRT
NON-FINAL ACTION E-MAILED
05/31/2023
CNRT
NON-FINAL ACTION WRITTEN
05/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/18/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/25/2022
GNRT
NON-FINAL ACTION E-MAILED
11/25/2022
CNRT
NON-FINAL ACTION WRITTEN
11/25/2022
DOCK
ASSIGNED TO EXAMINER
11/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/09/2022
NWAP
NEW APPLICATION ENTERED
02/08/2022
Continuous trademark protection
Get notified about every new filing that threatens CAREMATT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.